TalexMedical

About:

The proud producer of Infantear – a revolutionary Class I medical device for the treatment of external ear deformities in newborns.

Website: https://www.infantear.com/

Top Investors: BioAdvance

Description:

TalexMedical is the proud producer of Infantear – a revolutionary Class I medical device for the treatment of external ear deformities in newborns. InfantEar is a simple, yet elegant, nonsurgical ear molding system, applied in the outpatient setting, replacing the costly, labor intensive surgical ear procedure. The unique, fully customizable device is made of soft materials for increased comfort. Targeted primarily to pediatricians, who can recognize and treat the ear anomaly with one two-week treatment applied to a patient in the first three weeks of life, avoiding the delayed and costly external referral with specialists. This helps us to achieve the Triple Aim of Healthcare – improved results, increased patient satisfaction and decreased cost.

Total Funding Amount:

$500000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Philadelphia, Pennsylvania, United States

Founded Date:

2015-01-01

Contact Email:

kimcoffey(AT)infantears.com

Founders:

Scott Bartlett

Number of Employees:

1-10

Last Funding Date:

2017-08-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai